Silvercrest Asset Management Group LLC Astrazeneca PLC Transaction History
Silvercrest Asset Management Group LLC
- $14.6 Billion
- Q4 2024
A detailed history of Silvercrest Asset Management Group LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 288,071 shares of AZN stock, worth $21.2 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
288,071
Previous 200,857
43.42%
Holding current value
$21.2 Million
Previous $15.7 Million
20.6%
% of portfolio
0.13%
Previous 0.11%
Shares
11 transactions
Others Institutions Holding AZN
# of Institutions
1,351Shares Held
489MCall Options Held
5.88MPut Options Held
4.1M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.44 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.02 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.76 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.73 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.77 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $228B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...